Product details
Background:
similarity:Contains 2 EF-hand domains.,
- Please choose product options by visiting U-Blot® Research Grade Nirsevimab.
- Please choose product options by visiting CAC1F Polyclonal Antibody.
CaBP7 Polyclonal Antibody
Ucallm_WP11363-50
Price range: $268.00 through $328.00
Specifications
| Size | 50μL/100μL |
| Target | CaBP7 |
| Reactivity | Human, Mouse, Rat |
| Applications | WB, IHC, IF, ELISA |
| MW(Calculated) | |
| MW(Observed) | 25kD |
| Host Species | Rabbit |
| Isotype | IgG |
| Conjugate/Modification | Unmodified |
| Recommended Dilution Ratio | WB 1:500-1:2000; IHC 1:100-1:300; ELISA 1:10000; IF 1:50-200 / Note: For IHC, we suggest antigen retrieval with TE buffer pH 9.0 (Cat#WT1004) |
| Formulation | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Storage | -15°C to -25°C/1 year(Do not lower than -25°C) |
| Concentration | 1 mg/ml |
| Clonality | Polyclonal |
| Clone Number | |
| Immunogen | The antiserum was produced against synthesized peptide derived from human CABP7. AA range:1-50 |
| Specificity | CaBP7 Polyclonal Antibody detects endogenous levels of CaBP7 protein. |
| Gene Name | CABP7 |
| Protein Name | Calcium-binding protein 7 |
| Other Name | CABP7; / CALN2; / Calcium-binding protein 7; / CaBP7; / Calneuron II; / Calneuron-2 |
| Species | Human |
| Gene ID | 164633 |
| Uniprot | Q86V35, |
| Species.1 | Mouse |
| Gene ID.1 | 192650 |
| Uniprot.1 | Q91ZM8, |
| Species.2 | Rat |
| Gene ID.2 | 360970 |
| Uniprot.2 | Q66H96 |
| Cellular Localization | Golgi apparatus, trans-Golgi network membrane; Single-pass type IV membrane protein . Cytoplasm, perinuclear region . Cell membrane; Single-pass type IV membrane protein . |
| Tissue Expression | Brain,Epithelium, |
| Signaling_pathway | |
| Research Areas | |
| Function | similarity:Contains 2 EF-hand domains., |
Please login to post questions
Related products
